Latest News

Yingli Pharma presents a pivotal Phase 2 study data evaluating linperlisib in relapsed or refractory peripheral T-cell lymphoma in an oral session at the American Society of Hematology 2023 Annual Meeting

Linperlisib achieved Overall Response Rate of 48% with 30% being Complete Response and manageable safety profile in the r/r PTCL phase 2 study SHANGHAI and SAN FRANCISCO, Dec. 11, 2023 /PRNewswire/ -- Shanghai Yingli Pharmaceutical Co., Ltd. ("Yingli Pharma"), a biopharmaceutical company focused ...

2023-12-11 21:00 2500

Guide Sensmart was present at Big 5 Global 2023, advocating for the digitalization of inspections for building HVAC systems

WUHAN, China, Dec. 11, 2023 /PRNewswire/ -- As the largest HVACR exhibition in theMiddle East, the Big 5 Global 2023 was grandly held at the Dubai World Trade Centre in theUnited Arab Emirates from December 4th to December 7th. The four-day event attracted outstanding HVAC equipment manufacturers...

2023-12-11 21:00 4457

DST Raises US$80 Million in Latest Round of Financing

China's Leading NEV Fleet Management Company Secures One of the Largest US Dollar Private Investments in 2023  Highlights: * DST aims to expand the scale of its NEV fleet in China as well as to deepen its R&D efforts, increase offline service network, and offer comprehensive and tailor-made s...

2023-12-11 21:00 3262

INNOVATION TO INSPIRE, A WONDEROUS FUTURE | Tianma 2023 Global Innovation Conference, Seven Innovative Achievements Unveiled

XIAMEN, China, Dec. 11, 2023 /PRNewswire/ -- On November 27th, Tianma Innovation Conference (TIC) 2023 was held inXiamen with the theme of INNOVATION TO INSPIRE, A WONDEROUS FUTURE. Seven Innovative Achievements Seven I...

2023-12-11 20:21 2388

HanAll Biopharma's Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr. Almira Chabi, MD, EGMP to Board of Directors

WOBURN, Mass., Dec. 11, 2023 /PRNewswire/ -- HanAll Biopharma's partner NurrOn Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to developing novel, targeted therapeutics for the treatment of Parkinson's disease (PD) and other Nurr1-related human disorders, is pleased to...

2023-12-11 20:00 2808

Mabwell Announces the CDE Approval of Novel Nectin-4 Targeting ADC for Phase III Clinical Trial

SHANGHAI, Dec. 11, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its submission to the Center for Drug Evaluation (CDE) of the National Medical Products Administration for the "A Randomized, Open-label, Controlled, Mu...

2023-12-11 20:00 2159

Liangzhu Forum Enhances Cultural Exchanges among Silk Road Countries

HANGZHOU, China, Dec. 11, 2023 /PRNewswire/ -- A report from Xinhuanet North America:  With "Implementing the Global Civilization Initiative, Promoting Exchanges and Mutual Learning Between Civilizations" as its theme, the forum has a...

2023-12-11 19:41 2564

2023 SABCS | Laekna Reports Afuresertib Phase Ib Breast Cancer Study Results

-     A multi-center phase Ib/III study in China and the United States led by ProfessorBinghe Xu, MD, PhD, Academician of the Chinese Academy of Engineering -     70% of the patients enrolled in phase Ib study were previously treated with CDK4/6 inhibitors  -     Demonstrated a confirmed objecti...

2023-12-11 18:55 2446

Qudian Inc. Reports Third Quarter 2023 Unaudited Financial Results

XIAMEN, China, Dec. 11, 2023 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company, today announced its unaudited financial results for the quarter endedSeptember 30, 2023. Third Quarter 2023 Financial Highlights: * Total revenues w...

2023-12-11 18:00 4263

Delta's COP28 Side Event Shares Experience in Internal Carbon Pricing, Echoing COP28's "Climate Finance" Focus

TAIPEI, Dec. 11, 2023 /PRNewswire/ -- Delta Electronics has just organized a side event at the 28th Conference of the Parties(COP28) to the United Nations Framework Convention on Climate Change (UNFCCC), focusing on "Climate Finance", one of the main themes ofCOP28. Delta's participation this yea...

2023-12-11 17:47 2331

citizenM Menlo Park Hotel Jointly Built by CIMC Group Officially Opened in Silicon Valley, USA

SHENZHEN, China, Dec. 10, 2023 /PRNewswire/ -- Recently, the iconic citizenM Menlo Park Hotel, officially opened. InCalifornia's Silicon Valley, The manufacture of the 240 modular guest rooms was completed 1 year ago, when the modules were shipped fromChina to the United States and assembled on-s...

2023-12-11 13:44 6086

CM Energy Led Consortium Won US$163.8 Million Order for Oil Rig Moderation and O&M Services in Mexico

HONGKONG  , Dec. 11, 2023 /PRNewswire/ -- On December 11, 2023, TSC Manufacturing and Supply LLC ("TSC"), basedin Houston Texas, a wholly-owned subsidiary of CM Energy Tech Ltd., received the first order of land rig modernization contract from PetróleosMexicanos (PEMEX) in the amount of US$13,21...

2023-12-11 13:36 2496

Live from ASH 2023 | Ascentage Pharma Presents Updated Data from US Study of Olverembatinib, Further Validating Encouraging Efficacy in Patients Resistant to Ponatinib or Asciminib

SUZHOU, China, and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated data from a US study ...

2023-12-11 13:30 2257

Live from ASH 2023 | Ascentage Pharma Releases Encouraging Long-Term Data of Bcl-2 Inhibitor Lisaftoclax in R/R CLL, Including an ORR of 73.3%

SUZHOU, China and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released the latest efficacy and safety...

2023-12-11 13:14 2273

Live from ASH 2023 | Ascentage Pharma Releases the First Dataset of Bcl-2 Inhibitor Lisaftoclax in Patients with R/R MM, Demonstrating Encouraging ORR and VGPR

SUZHOU, China and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released the clinical data of lisaftocl...

2023-12-11 12:56 1844

DHGATE Group Co-CEO Chun Li, Addresses the 2023 GoGlobal Forum of 100, Advocates for Enhanced Services to Uplift Global Small Businesses

SHANGHAI, Dec. 10, 2023 /PRNewswire/ -- DHGATE Group , China's leading B2B cross-border e-commerce marketplace,announced that its Co-CEO, Chun Li, participated in the prestigious "2023 GoGlobal Forum of 100" inShanghai. At the event, Li Chun shared insights on adva...

2023-12-11 12:41 2457

InfiRay Plans to Unveil Its Latest Car Night Vision AI System at CES 2024

YANTAI, China, Dec. 10, 2023 /PRNewswire/ -- Over the past decade, InfiRay, a world-renowned thermal camera manufacturer, has made continuous efforts and progress in the infrared field and achieved innovations and breakthroughs in microwave and rangefinding. InfiRay announces that it will present...

2023-12-11 12:11 2577

MGI Expands Presence in Latin America with New Partnerships with Genos Médica and TCL Group

SAO PAULO, Dec. 10, 2023 /PRNewswire/ -- MGI Tech Co. Ltd., a company committed to building core tools and technology to lead life science, today announced partnerships with Genos Médica, aMexico-based specialized center in genomics, and TCL Group, a company dedicated to the import and sales of l...

2023-12-11 11:26 2660

Last Fortress x The Boys Collaboration Round 2! Homelander, Soldier Boy, and A-Train Join the Fight!

NEW YORK, Dec. 10, 2023 /PRNewswire/ -- Embark on an epic journey in the groundbreaking survival game, Last Fortress: Underground, as it kicks off its second collaboration with the viral superhero TV series, The Boys. Iconic characters from The Boys—Homelander, Soldier Boy, and A-Train—will set ...

2023-12-11 10:30 2667

AndaSeat Unveils a Festive Collection of Gaming Gear: Gaming in a Winter Wonderland

LOS ANGELES, Dec. 10, 2023 /PRNewswire/ -- This holiday season, AndaSeat is inviting gamers to experience the wonder of a winter wonderland with a festive lineup of gaming chairs and desks that bring the joy of Christmas to every home office and gaming setup. As the yuletide carols fill the air, ...

2023-12-11 10:22 2366